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Mechanistic investigations of the asymmetric hydrosilylation of 
ketimines with trichlorosilane reveals a dual activation model and 
an organocatalyst with enhanced efficiency 
X. Li,a A. T. Reeder,a F. Torri,a H. Adamsa and S. Jones*a. 
Structural probes used to help elucidate mechanistic information of the organocatalyzed asymmetric ketimine 
hydrosilylation have revealed a new catalyst with unprecedented catalytic activity, maintaining adequate performance at 
0.01 mol% loading. A new ‘dual activation’ model has been proposed that relies on the presence of both a Lewis basic and 
Brønsted acidic site within the catalyst architecture. 
Introduction 
The organocatalyzed asymmetric hydrosilylation of ketimines 
provides an effective method to prepare chiral amines in good 
yield and enantioselectivity. Since the first chiral Lewis-base 
derived catalyst was reported in 2001,1 there have been many 
variants of catalyst prepared and evaluated;2,3 selected 
examples include formamides,4–7 sulfinimides,8,9 pyridines,10–12 
and organophosphorus compounds.13–15 The main focus of 
research from this group has been using an imidazole derived 
catalyst that has been shown to function as efficiently as the 
reported analogous picolinoyl series,16 in addition to being 
amenable to reductive amination protocols.17 Despite it being 
more than a decade since the first asymmetric catalysts for 
this type of transformation were reported, mechanistic data 
and insights have been sporadic, and only tentative models 
have been put forward to explain the selectivity.18 The most 
comprehensive study to date is that put forward by Malkov et 
al.,19 crucially noting the dependence of adventitious Brønsted 
acids to ensure the success of these reactions. Given the 
scarcity of mechanistic detail for these catalytic processes, a 
more in depth structural analysis of the imidazole catalyst 
system developed in these laboratories has now been 
conducted, providing new insights into the mechanism of this 
process, and has delivered a new catalyst with even higher 
activity. 
Results and discussion 
The role of the Lewis basic amide in relation to the imidazole 
ring system was first investigated. A series of N-substituted 
imidazoles and their corresponding dimethylamides were 
prepared. 1-Methylimidazole 1 is commercially available, 
whereas 1-tert-butylimidazole 2 was prepared by condensing a 
mixture of glyoxal, aqueous formaldehyde, aqueous ammonia 
and tert-butylamine.20 These were converted to the 
dimethylamides 3 and 4 by deprotonation with n-BuLi and 
quenching with dimethylcarbamoyl chloride (Scheme 1), and 
evaluated in a benchmark HSiCl3 reduction of the N-PMP 
acetophenone ketimine 5 under a standard set of reaction 
conditions by removing aliquots and analyzing the conversion 
by 1H NMR spectroscopy (Figure 1). N,N-Dimethyl benzamide 
was included as a benchmark to compare the role of the 
imidazole nitrogen atom. 
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Scheme 1. Synthesis and evaluation of imidazole catalysts 1–4 and N,N-dimethyl 
benzamide. 
The data obtained show slightly different reactivities between 
the N-Me and N-t-Bu catalysts 1 and 2 but this may be due to 
the N-Me catalyst not being completely soluble in DCM. 
However, what is noticeable is the significant difference in 
reaction rate between the two model dimethylamide catalysts; 
the N-Me catalyst 3 showed a significant increase in relative 
reaction rate compared to the parent imidazole, whilst the N-t-
Bu catalyst 4 reaction rate dropped. This leads to the relative 
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initial rate of the N-Me catalyst being of the order of 4 times 
faster than that of the N-t-Bu one. By comparison to the 
imidazole catalysts, N,N-dimethyl benzamide was a very poor 
catalyst, barely operating above the background reaction rate 
for these type of processes. 
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Figure 1. Relative reaction rates of imidazole catalysts 1–4 and N,N-dimethyl 
benzamide. Reactions performed using 10 mol% catalyst, 2 equiv HSiCl3 in DCM 
(1 mL mmol-1) at 0 oC. Conversion calculated from comparison of appropriate 
integrals in 1H NMR spectrum of aliquots removed from reaction. 
In order to probe this further, both dimethylamide catalysts 3 
and 4 were studied using in-situ infra-red experiments. The 
absorption signal of the carbonyl group of N-Me catalyst 3 in 
DCM initially appeared at 1635 cm
-1 and after addition of one 
equivalent of HSiCl3, a new signal immediately appeared at 
1668 cm-1, while the original signal at 1635 cm-1 
simultaneously disappeared (Figure 3). Addition of further 
equivalents of HSiCl3 led to no additional change other a 
dilution effect (observed in the slight drop of the signal at 1668 
cm-1 after 8 mins). This suggests that coordination of HSiCl3 
with the amide is rapid and complete for this catalyst. In the 
case of the N-t-Bu catalyst 4, the original signal of the carbonyl 
group was at 1645 cm-1 with a smaller new signal appearing at 
1671 cm-1 once treated with one equivalent of HSiCl3. 
Noticeably, in this case significant amounts of the un-
coordinated catalyst were still present compared to the N-Me 
catalyst 3 and this ratio did not change with time, or when a 
further equivalent of HSiCl3 was added. This suggests that 
coordination of this catalyst to HSiCl3 is more difficult than in 
the case of the N-Me catalyst 3, and that steric effects of the 
imidazole N-alkyl group play an important role in the activity of 
such catalysts. In complete contrast, N,N-dimethyl benzamide, 
showed no change in the carbonyl group signal, correlating 
with its poor reactivity.  
For this series of compounds, it seems that the extent of 
coordination of the HSiCl3 with the carbonyl group is a 
reasonable measure of catalytic activity. The N-Me and N-t-Bu 
catalysts are likely to incur different and significant energetic 
penalties for the interaction of the amide N-methyl groups 
with the imidazole alkyl substituent, in either case probably 
ruling out a truly co-planar species 7a. This probably favours a 
stable conformation that places the carbonyl group and 
imidazole ring orthogonal to each other i.e. structure 7b in 
Figure 2 (note that these are depicted as reactive 
conformations, not active catalytic species that might be 
protonated at the imidazole nitrogen atom, vide infra). The 
increasing torsional angle then in-turn increases the distance 
of the silicon and imidazole nitrogen atoms, reducing 
reactivity, fitting well with observations with the N,N-dimethyl 
benzamide system, lacking any cooperative effect of the 
imidazole nitrogen atom. 
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Figure 2. Reactive conformations of catalysts 3 & 4. 
 
 
 
 
Figure 3. From left to right; in-situ IR data of N-Me catalyst 3 treated with HSiCl3 as a function of time; in-situ IR data of catalyst N-t-Bu 4 treated with HSiCl3 as a 
function of time; in-situ IR data of N,N-dimethyl benzamide treated with HSiCl3 as a function of time. 
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Scheme 2. Synthesis of catalysts 14–17. 
Naturally, these catalyst fragments lack the prolinol moiety 
that might have synergistic effects when considering the whole 
catalyst system. Thus any speculation about mechanism for 
these simple amides might not directly translate to more 
complex systems. Thus, in order to further probe such 
interactions, a series of chiral heterocyclic catalysts were 
investigated containing a prolinol derived backbone that were 
prepared starting from their parent carboxylic acids. Thus, 1-
methylimidazole-4-carboxylic acid 9 is commercially available, 
and 1-methylpyrrole-2-carboxylic acid 10 was obtained by 
hydrolysis of the methyl ester 12 with aqueous potassium 
hydroxide. 1-t-Butylimidazole-4-carboxylic acid 11 was 
accessed by deprotonation of 1-t-butylimidazole 2 with n-BuLi 
then quenching with ethyl chloroformate to give the ester 8, 
followed by basic hydrolysis. These three heterocyclic 
carboxylic acids 9–11 were transformed into the respective 
acid chlorides with oxalyl chloride, followed by immediate 
coupling with α,α-diphenylprolinol 13 giving catalysts 14–16, 
with previously reported catalyst 17 being prepared by a 
similar method as previously described (Scheme 2).16 
All of these new catalysts were then evaluated under the 
standard set of reaction conditions (Scheme 1, Figure 4). The 
isomeric imidazole 14 was active but led to poor selectivity 
delivering the opposite enantiomer of product amine 6 to that 
normally observed. Given the torsional freedom that this 
isomeric system has compared to the parent imidazole catalyst 
17, it is likely that an alternative reactive conformation may be 
accessible in this case, perhaps even a co-planar species 
analogous to 7a, resulting in a competitive pathway with a 
different stereochemical bias. The N-Me pyrrole catalyst 15 
was essentially inactive which is interesting as it indicates that 
the amide functionality alone is not sufficient to promote this 
reaction. Based on the kinetic data for the dimethylamide 
catalyst 4, perhaps unsurprisingly the N-t-Bu catalyst 16 was 
essentially inactive, the 15% conversion being typical of the 
background reaction rate for this process. None of these 
surpassed the performance of the previously reported catalyst 
17. This compares well with the findings with the simple, 
achiral catalysts 3 and 4, whereby torsional freedom around 
the imidazole – carbonyl bond to appropriately locate the 
imidazole nitrogen atom is critical for high catalytic activity. 
The previously reported development of the imidazole catalyst 
17 clearly demonstrated some key requirements in order to 
obtain both high yields and selectivity.16 Most critical for 
obtaining high selectivities was use of a gem-diaryl group. This 
most likely relays stereochemical information from the 
adjacent proline stereogenic center to create a chiral 
environment that facilitates the required facial differentiation 
of the planar ketimine. 
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Figure 4. Evaluation of prolinol catalysts 14–17 according to Scheme 1. 
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Figure 5. Synthesis of catalyst 21 and comparison of activity with previous catalysts in the reduction of N-PMP ketimine 5 as shown in Scheme 1. 
In order to investigate this further, the gem-dimethyl catalyst 
21 was prepared by coupling (S)-α,α-dimethylprolinol 19 
(obtained from reaction of ester 18 with an excess of MeMgI, 
followed by hydrolysis) with ethyl N-methyl imidazole-1-
carboxylate 20 and evaluated in the benchmark reduction of 
the N-PMP-ketimine of acetophenone 5 (Figure 5, Scheme 1). 
Noticeably, although the conversion to product was 
approximately the same as other catalysts previously 
prepared, the enantioselectivity was lower than that of the 
gem-diaryl catalyst 17, and similar to the catalyst 22 without 
the gem-dimethyl group. Thus, the role of this component may 
not simply be steric, an effect that has been previously 
documented for gem-diaryl groups.21 
In the final stages of catalyst evaluation, the role of the 
hydroxyl group was examined. Matsumura’s work had 
previously shown that the deoxy-picoline derivative 24 
catalyzed the asymmetric hydrosilylation of N-phenyl ketimine 
25 but led to poor selectivity compared to the parent catalyst 
23, inferring the need for a hydrogen bond to effectively 
coordinate with the ketimine substrate, leading to the 
commonly accepted model shown.12 In order to compare this 
effect in the imidazole series, removal of the hydrogen bond 
acceptor was achieved by methylation of catalyst 17 with 
sodium hydride and methyl iodide giving the O-Me catalyst 26 
in 56% yield (Scheme 3). For comparison purposes, 
Matsumura’s picolinic acid derived catalyst 23 was prepared 
from commercially available 2-picolinic acid by treating with 
oxalyl chloride, then reaction with α,α-diphenylprolinol 13. 
This was also O-methylated in analogous fashion to give 
catalyst 27 in 83% yield. These catalysts were then evaluated 
in the benchmark reduction of the N-PMP ketimine 5, each 
being challenged at low catalyst loadings to better determine 
efficacy (Table 1). Commercially available Sigamide® 28 was 
also included to provide a frame of reference.
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Scheme 3. Matsumura’s picolinoyl catalysts 23 & 24 and selectivity model, synthesis of O-methyl catalysts 26 & 27, and structure of Sigamide® 28. 
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Table 1. Evaluation of catalysts 17, 23, 26–28 according to the reaction shown in 
Scheme 1.a 
Entry Catalyst Catalyst loading 
(mol %) 
Conversion 
(%)b 
ee (%)c ACEd 
1 17 
 
1 100 90 56 
2 0.1 88 87 481 
3 0.01 60 80 3018 
4 26 1 100 91 58 
5 0.1 100 89 538 
6 0.01 96 84 4881 
7 23 1 100 79 50 
8 27 1 100 56 34 
9 0.1 95 62 359 
10 0.01 25 NDe  
11 28 1 60 80 31 
a Reactions conducted with N-PMP-ketimine 5 (1 mmol), HSiCl3 (2 mmol) at the 
specified catalyst loading in DCM (0.5 mL) at 0 oC for 4 h, followed by aqueous 
workup; b Conversion calculated by comparison of the value of the integrals for 
the product to residual ketimine and ketone (from hydrolysis); c Determined by 
chiral phase HPLC analysis; d See reference 22; e Not determined. 
Imidazole derived catalyst 17 performed as expected, its 
reactivity dropping off slightly with reduced loading, but still 
acting in a reasonably stereoselective manner (Table 1, entries 
1-3). However, completely unexpectedly, methylated 
imidazole catalyst 26 showed superior activity and selectivity 
at even as low as 0.01 mol% loading (entries 4-6). Calculation 
and comparison of the Asymmetric Catalytic Efficiency (ACE)22 
factor at each of the catalyst loadings highlights the 
exceptional activity of methoxy catalyst 26 at low catalyst 
loading (Table 1, compare entries 3 & 6). Given the accepted 
hypothesis of the importance of the hydrogen bond, this is a 
remarkable and unprecedented result. Interestingly, a broadly 
similar trend was observed with the picoline catalysts 23 and 
27 although not at the same performance level as the 
imidazole ones (entries 7-10). Under the conditions used, 
Sigamide® 28 did not perform as well as the other catalysts 
(entry 11). 
The enhanced catalytic activity of catalyst 26 was exemplified 
with a small representative selection of ketimines 29–33, with 
conversion and enantioselectivities of the product amines 34–
38 comparable to those obtained at higher loading using 
catalyst 17 (Scheme 4, Table 2). Given the structural similarity 
of these catalysts it is not surprising that the 
stereodifferentiating elements result in comparable 
selectivities and further exemplification and optimisation of 
reaction parameters was not carried out. 
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Scheme 4. Substrate scope with catalysts 17 and 26. 
The remarkable and unexpected catalyst activity, presumably 
due to the absence of the hydrogen bond, warranted further 
investigation. The difference in hydroxy and methoxy catalysts 
17 and 26 is first evident from their 1H NMR spectra. Hydroxy 
catalyst 17 has a very broad and almost uninterpretable 
spectrum in CDCl3 at room temperature and is best recorded in 
DMSO at 100 oC in order to obtain the best resolution signals, 
presumably due to the presence of an internal hydrogen bond, 
although this is not evident in the single crystal X-ray crystal 
structure (see electronic supplementary information). In 
contrast, methoxy catalyst 26 provides a much better resolved  
Table 2. Substrate scope of catalysts 17 and 26 according to the reaction shown in Scheme 4 a 
Entry Catalyst (loading / mol %) R1 R2 imine amine Conversion (%)b ee (%)c 
1 26 (0.1) Ph 4-FC6H4 29 34 95 86 
2 17 (1) Ph 4-FC6H4 29 34 96 87 
3 26 (0.1) 4-MeOC6H4 4-MeOC6H4 30 35 97 84 
4 17 (1)d 4-MeOC6H4 4-MeOC6H4 30 35 81 85 
5 26 (0.1) 4-NO2C6H4 4-MeOC6H4 31 36 98 84 
6 17 (1)d 4-NO2C6H4 4-MeOC6H4 31 36 85 86 
7 26 (0.1) 2-Thienyl 4-MeOC6H4 32 37 77 80 
8 17 (1)e 2-Thienyl 4-MeOC6H4 32 37 61 79 
9 26 (0.1) β-Naphthyl 4-MeOC6H4 33 38 99 92 
10 17 (1)d β-Naphthyl 4-MeOC6H4 33 38 86 86 
a Reactions conducted with ketimine (1 mmol), HSiCl3 (2 mmol) at the specified catalyst loading in DCM (0.5 mL) at 0 
oC for 4 h, followed by aqueous workup; b 
Conversion calculated by comparison of the value of the integrals for the product to residual ketimine and ketone (from hydrolysis); c Determined by chiral phase HPLC 
analysis; d Literature values, see reference 16; e Using reductive amination protocol, see reference 17. 
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Figure 6. Plot of product 5 ee vs catalyst ee 17.  
spectrum at room temperature in CDCl3, existing as two 
rotameric forms in a 4.5:1 ratio. 
In an attempt to elucidate the mechanism further, the 
relationship of product ee and catalyst ee was examined using 
the N-PMP-ketimine substrate 5 and hydroxy catalyst 17. 
Plotting this gave a linear relationship (Figure 6), indicating 
that one molecule of catalyst was involved in formation of the 
catalytically active species. Furthermore, the ee of the product 
remained constant over the duration of the experiment.  
Since the critical unusual feature that was observed in this 
catalyst screen related to the hydroxyl group, further efforts 
were made to examine the chemistry around this centre by 1H 
NMR and 29Si NMR experiments. The reduction of N-PMP 
ketimine 5 was performed with HSiCl3 (2 equiv) in CDCl3 with 1 
mol% imidazole catalyst 17. 
 
Figure 7. In situ 1H and 29Si NMR spectra of reaction products as depicted in Scheme 1 with catalyst 17. 
 
Figure 8. 1H and 29Si NMR spectra of catalyst 17 and excess HSiCl3. 
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After 4 h, 1H NMR and 29Si NMR spectroscopy indicated that 
the main species resulting from the reduction were N-SiCl2H 
amine 39 (δH 5.55 ppm and δSi -9.7 ppm) and silicon 
tetrachloride (δSi -18.9 ppm) (Figure 7). The identity of the 
former species was confirmed by independent synthesis by 
addition of trichlorosilane to a sample of N-PMP-α-
methylbenzylamine 6, and the latter by comparison with a 
reference sample. It is noticeable that the silicon tetrachloride 
results from the reaction and is not present in the HSiCl3. 
When hydroxy catalyst 17 was treated with an excess of 
trichlorosilane, new signals were observed in the 1H NMR (δH 
4.99 ppm) and 29Si NMR (δSi -33.2 ppm) spectra. These signals 
are consistent with an oxosilane species formed by silylating 
the hydroxyl group of catalyst 17, confirmed by comparison of 
the 1H and 29Si chemical shifts of the related EtOSiCl2H in the 
literature, including JSi-H coupling of 
29Si satellite signals in the 
1H NMR spectrum (Figure 8).23 Importantly, the 29Si NMR 
spectrum only provided evidence for a tetra-coordinate silicon 
atom. The 1H NMR spectrum also shows a significant downfield 
chemical shift of the methine proton adjacent to the amide 
nitrogen atom that might result as a combination of the loss of 
the internal hydrogen bond and from complexation of the 
carbonyl group to the silane. The spectrum also has 
considerably better resolved signals than that obtained for the 
parent catalyst at room temperature, implying fewer 
equilibrating rotameric and / or hydrogen bonded species. In 
retrospect, this is what one would expect from the natural 
reactivity of a chlorosilane with an alcohol to generate a silyl 
ether and HCl. Given the formation of the latter, it is also very 
likely that the imidazole of the catalyst will be protonated. 
Importantly, this preformed catalyst – trichlorosilane complex 
40 demonstrated the same catalytic activity in the standard  
 
Figure 9. 1H NMR spectrum of catalyst 26 before and after addition of 4 equiv HSiCl3. 
asymmetric hydrosilylation reaction, and returned unchanged 
catalyst after work-up. In contrast, no new signals were 
observed in the 29Si NMR spectrum of the methoxy catalyst 26 
when treated with trichlorosilane, which was corroborated by 
the presence of only a very small signal at δH 5.27 ppm in the 
1H NMR spectrum where evidence of a Si-H signal might be 
observed (Figure 9). However, significant chemical shift 
changes were observed in the imidazole and methine protons, 
in addition to those signals corresponding to the pyrrolidine 
ring. As in the case of the hydroxyl-catalyst 17, these changes 
may have resulted from protonation of the imidazole, in this 
case from adventitious HCl usually found in HSiCl3.  
The presence of HCl and protonation of the catalysts appeared 
to be a key factor in their activity, and related studies have 
also shown that additives such as water (to form HCl in situ), 
acetic acid, and benzoic acid can improve the catalytic 
activity.6,7,9,24,25 As previously indicated, HCl is most likely also 
present in commercial HSiCl3, and to confirm the effect of this, 
a series of reactions were performed under diluted conditions 
in order to slow them down sufficiently to observe positive or 
negative effects of the effects of proton sponge, HCl and 
chloride ions (in the form of n-BuN4Cl). None of these additives 
catalysed the reaction in the absence of the catalysts, and 
reactions conducted with the hydroxy 17 and methoxy 26 
catalysts showed that the presence of HCl was essential for 
reactivity (Table 3, entries 2 and 7).  
Table 3. Effect of proton sponge, n-Bu4NCl, and HCl on catalysts 17 and 26 according to 
reaction shown in Scheme 1.a 
Entry Catalyst (loading / mol%) Additive (equiv) Conversion / %b 
1 17 (0.1) None 57 
2 17 (0.1) Proton sponge (1) 0 
3 17 (0.1) n-Bu4NCl (0.1) 61 
4 17 (0.1) HCl (0.005) 60 
5 17 (0.1) HCl (0.05) 58 
6 26 (0.01) None 13 
7 26 (0.01) Proton sponge (1) 0 
8 26 (0.01) n-Bu4NCl (0.1) 15 
9 26 (0.01) HCl (0.005) 15 
10 26 (0.01) HCl (0.05) 16 
a Reactions conducted with N-PMP-ketimine 5 (1 mmol), HSiCl3 (2 mmol) with the 
specified additive and catalyst loading in DCM (5 mL) at 0 oC for 1 h, followed by 
aqueous workup; b Conversion calculated by comparison of the value of the 
integrals for the product to residual ketimine and ketone (from hydrolysis). 
As conducted with catalysts 3 and 4, investigation of the 
reactive catalyst species was conducted by in-situ infra-red 
analysis (Figure 10 and Figure 11). Upon addition of 1 equiv of 
HSiCl3, the hydroxy catalyst 17 shows a rapid and complete  
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Figure 10. In-situ IR data of catalyst 17 treated with HSiCl3 as a function of time. 
 
Figure 11. In-situ IR data of catalyst 26 treated with HSiCl3 as a function of time. 
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Figure 12. Proposed dual activation mechanism for catalyst 17. 
change in the stretching frequency of the carbonyl group, 
whilst catalyst 26 shows a rapid but incomplete change, 
suggesting an equilibrium process. This is very similar to the 
behaviour with the simpler catalysts 3 and 4, however the 
reactivity is inverted, with catalyst 26 showing incomplete 
complexation being more active. Since no direct reaction with 
HSiCl3 is possible here as corroborated by 
29Si NMR data, the 
changes in the 1H NMR and IR data indicate a different resting 
state for the catalyst, perhaps with the imidazole being 
protonated by the small quantities of HCl present in the HSiCl3. 
Catalyst 17 reacts stoichiometrically with HSiCl3, in doing so 
generating HCl to completely protonate the imidazole. 
Based on these results, a new ‘dual activation’ mechanistic 
model is proposed that involves a Lewis basic site to activate 
the HSiCl3 and an additional Brønsted base capable of reacting 
with HCl generated or present in the reaction (Figure 12). 
Reaction of the hydroxy catalyst 17 with HSiCl3 provides a 
covalently linked siloxane 40 where the imidazole is 
protonated by HCl, either as a by-product from reaction with 
the alcohol, or from adventitious HCl in the HSiCl3. This is the 
resting state for the catalyst that is set up for forming a key 
hydrogen bond with the ketimine substrate.  
Coordination of the silane with the Lewis basic amide inferred 
from the in situ infra-red studies must involve twisting of the 
amide bond to negate steric interactions, leading to a reactive 
hexa-coordinate species 41. The ketimine substrate is now 
activated by a hydrogen bond to the protonated imidazole, 
and placed in the correct orientation to facilitate hydride 
delivery from the activated siloxane. Importantly, the N-PMP-
amine product 6 then undergoes reaction with more 
trichlorosilane to generate the observed N-SiHCl2 product 39, 
whilst the inactive catalyst 42 turns-over by protonation and 
reaction with more trichlorosilane, generating silicon 
tetrachloride. This accounts for the observation that the 
reaction slows considerably when using less than 2 equivalents 
of HSiCl3. 
This model essentially inverts that proposed by Matsumura 
(Scheme 3), with the crucial hydrogen bond now being located 
at the imidazole nitrogen atom. However, the deoxy catalyst 
23 may still react via the previously accepted model, especially 
as there is some similarity between the sense and magnitude 
of the selectivity observed with catalyst 14 (Figure 4). 
The process with methoxy catalyst 26 is more complex since 
no evidence could be obtained for a species whereby HSiCl3 is 
bound to the catalyst. Clearly there is a change in the 1H NMR 
and IR data on addition of HSiCl3 that may be due to reaction 
with HCl (Figure 13). Naturally this means that no Si-O bond 
needs to be broken after reduction of the C=N bond and 
therefore the catalyst can turn-over more quickly, perhaps 
explaining the enhanced catalytic activity. A completely 
different mechanism is unlikely due to the similar levels of 
enantioselectivity that catalysts 17 and 26 provide. 
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Figure 13. Postulated resting state 43 and intermediate in dual activation mechanism 
with methoxy catalyst 26. 
Such a dual activation model is obviously transferable to the 
Matsumura and related picoline systems, the difference in 
reactivity probably now coming from the different torsional 
freedom and basicity provided by the 2-pyridyl moiety. The 
model previously proposed for related N-formamide catalysts 
such as Sigamide® 28 also contains key elements of this dual 
activation mechanism, with the Brønsted acid now being the 
relatively acidic aniline NH proton (Figure 14). 
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Figure 14. Previously reported model for Sigamide 28 illustrating dual activation. 
Conclusion 
In summary, a dual-activation mechanism is proposed for the 
organocatalyzed asymmetric hydrosilylation of ketimines. This 
model fits the available mechanistic and characterization data 
and in doing so has provided an example of a new catalyst 
system displaying catalytic activity at unprecedented low levels 
of catalyst loading. Computational studies on these systems 
may reveal more details to support these studies. This work 
should provide valuable insights for the future design and 
mechanistic rationale for new catalysts in this area. 
Experimental section 
General experimental methods 
All solvents were obtained from a dry solvent system and  
glassware was flame dried and cooled under vacuum before 
use. All dry reactions were carried out under a nitrogen 
atmosphere. TLC was carried out using aluminium TLC sheets 
(silica gel 60 F254), and visualised using a UV lamp or by dipping 
in KMnO4 solution then exposure to heat. Flash column 
chromatography was carried out with silica gel 40-63 60Å. 1H, 
13C NMR and 29Si spectra were measured using CDCl3 as 
solvent unless otherwise stated. 13C NMR spectra were 
recorded using the JMOD method. Specific rotations were 
measured at 589 nm (Na D-Line) at 20 oC unless otherwise 
stated, and are given in 10-1 deg cm2 g-1. All chemicals were 
used as received without further purification. Previously 
reported methods were used to prepare the following 
compounds: N-PMP-ketimine 5, (S)-α,α- diphenylprolinol 13, 
N-Me-catalyst 17, (S)-N-ethoxycarbonylproline methyl ester 
18, ethyl N-methyl imidazole-1-carboxylate 20, 4-methoxy-N-
[1-(4-nitrophenyl)ethylidene]benzenamine 31, 4-methoxy-N-
[1-(2-naphthalenyl)ethylidene]benzenamine 33;16 4-fluoro-N-
(1-phenylethylidene)benzenamine 29, 4-methoxy-N-[1-(4-
methoxyphenyl)ethylidene]benzenamine 30;26 N-4-methoxy-
N-[1-(2-thienyl)ethylidene]benzenamine 32.19 
1-t-Butylimidazole 2 
The title compound was prepared using a modified literature 
procedure.20 A 250 mL three-necked flask containing distilled 
water (50 mL) was equipped with two dropping funnels and a 
condenser. One dropping funnel was filled with a mixture of 
40% aqueous glyoxal (11.5 mL, 0.1 mol) and 37% aqueous 
formaldehyde (8.10 g, 0.1 mol), the other with t-butylamine 
(10.6 mL, 0.1 mol) and 35% aqueous ammonia (4.86 g, 0.1 
mol). The water was heated until boiling, and then both 
solutions were added simultaneously at the same addition 
rate. The resulting mixture turned brown and was stirred for 
30 min at reflux after complete addition, and then cooled to rt. 
The mixture was extracted with DCM (3 × 150 mL), the 
combined organic phases were washed with brine (50 mL) and 
dried over MgSO4. The desiccant was filtered off and the 
filtrate was evaporated. The brown residue was purified by 
vacuum distillation to give the product 2 as a colourless oil 
(4.80 g, 39%); δH
 (400 MHz, CDCl3): 1.55 [9H, s, (CH3)3C], 7.03 
(1H, s, ArCH), 7.04 (1H, s, ArCH), 7.60 (1H, s, ArCH); δC (100 
MHz, CDCl3): 30.6 [C(CH3)3], 54.7 [C(CH3)3], 116.3 (ArCH), 129.1 
(ArCH), 134.3 (ArCH); Data were in accordance with the 
literature. 
1-Methyl-N,N-dimethyl-1H-imidazole-2-carboxamide 3
27
 
N-Methylimidazole 1 (1.64 g, 20 mmol) was dissolved in THF 
(20 mL) and cooled to -78 °C. n-BuLi (2.5 M in hexanes, 10 mL, 
25 mmol) was added dropwise by syringe. The resulting 
mixture was stirred at -78 °C for 2 h. This solution was added 
dropwise to a solution of dimethylcarbamoyl chloride (2.99 g, 
28 mmol) in diethyl ether (25 mL) at -78 °C and stirred for 1 h 
at the same temperature. The reaction mixture was then 
warmed to rt and quenched with water (50 mL). The organic 
solvent was evaporated and the aqueous was extracted with 
DCM (3 × 30 mL) and dried over MgSO4. The desiccant was 
filtered off and the filtrate was evaporated to give the crude 
residue, which was purified by chromatography on silica gel 
[50% ~ 100% ethyl acetate in petroleum ether (40-60)] to yield 
the product 3 as a colourless oil (1.10 g, 36%); δH (400 MHz, 
CDCl3): 3.12 (3H, s, CH3), 3.41 (3H, s, CH3), 3.89 (3H, s, CH3), 
6.94 (1H, d, J 1.0, ArCH), 7.05 (1H, d, J 1.0, ArCH); δC (100 MHz, 
CDCl3): 35.0 (CH3), 35.7 (CH3), 39.3 (CH3), 123.6 (ArCH), 127.3 
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(ArCH), 140.1 (ArC), 160.9 (CO); Data was in accordance with 
the literature. 
1-t-Butyl-N,N-dimethyl-1H-imidazole-2-carboxamide 4 
1-t-Butylimidazole 2 (2.48 g, 20 mmol) was dissolved in THF 
(20 mL) and cooled to -78 °C. n-BuLi (2.0 M in hexanes, 12.5 
mL, 25 mmol) was added dropwise by syringe. The resulting 
mixture was stirred at -78 °C for 2 h. This solution was added 
dropwise to a solution of dimethylcarbamoyl chloride (2.99 g, 
28 mmol) in diethyl ether (20 mL) at -78 °C and stirred for 1 h 
at the same temperature. The reaction mixture was then 
warmed to rt and quenched with water (50 mL). The organic 
solvent was evaporated and the aqueous was extracted with 
DCM (3 × 100 mL) and dried over MgSO4. The desiccant was 
filtered off and the filtrate was evaporated to give the crude 
residue. Pure product 4 was obtained as a white solid after 
recrystallization from ethyl acetate (1.69 g, 43%); m.p. 146–
148 °C; νmax (thin film): 3157 (w), 2931 (w), 1638 (s), 1524 (w); 
δH (400 MHz, CDCl3): 1.60 [9H, s, (CH3)3C], 2.96 (3H, s, CH3), 
3.09 (3H, s, CH3), 6.97 (1H, d, J 1.2, ArCH), 7.05 (1H, d, J 1.2, 
ArCH); δC (100 MHz, CDCl3): 30.4 (CH3), 35.0 (CH3), 38.6 (CH3), 
57.0 [(CH3)2C], 117.9 (ArCH), 126.8 (ArCH), 140.3 (ArC), 164.5 
(CO); HRMS (ES+ TOF): found 196.1442 ([M + H]+); C10H18N3O 
requires 196.1450.  
Kinetic analysis of the reduction of ketimine 5 to amine 6 
N-PMP-Ketimine 5 (0.225 g, 1.0 mmol) and catalyst (mol% as 
specified) were dissolved in DCM (1 mL) at 0 oC. HSiCl3 (0.2 mL, 
2.0 mmoL) was added and the reaction left to stir for the 
specified time. Work-up, either after the reaction was 
complete, or by removal of samples during the reaction, was 
accomplished by dilution with DCM (20 mL per mL aliquot), 
quenching with aqueous NaOH (1 M, approximately 20 mL per 
mL aliquot), and separation of the organic layer. The aqueous 
layer was further extracted with DCM (2 × 20 mL per mL 
aliquot), the combined organic layers dried over MgSO4, 
filtered and evaporated. Conversion was calculated from 
comparison of the integrals corresponding to ketimine starting 
material(s) and ketone (from hydrolysis of the ketimine) and 
that of the product amine 6. δH (400 MHz, CDCl3): 1.52 (3H, d, J 
7.1, CH3), 3.70 (3H, s, CH3), 4.43 (1H, q, J 7.1, CH), 6.49 [2H, 
(AX)2, ArCH], 6.72 [2H, (AX)2, ArCH], 7.21–7.40 (5H, m, ArCH). 
Ethyl 1-t-butyl-1H-imidazole-2-carboxylate 8 
1-t-Butylimidazole 2 (4.34 g, 35 mmol) was dissolved in THF 
(30 mL) and cooled to -78 °C. n-BuLi (2 M in hexanes, 20 mL, 
40 mmol) was added dropwise by syringe. The resulting 
mixture was stirred at -78 °C for 2 h, and this solution added to 
a solution of ethyl chloroformate (7.56 g, 70 mmol) in THF (20 
mL) by cannula at -78 °C, followed by stirring for 1 h at the 
same temperature. The reaction mixture was then warmed to 
rt and quenched with saturated aqueous ammonium chloride 
(50 mL). The resulting mixture was extracted with ethyl 
acetate (4 × 100 mL), and the combined organic layers were 
washed with brine (100 mL) and dried over MgSO4. The 
desiccant was filtered off and the filtrate was evaporated. The 
residue was purified by chromatography on silica gel [(20% ∼ 
30% ethyl acetate in petroleum ether(40-60)] to yield the 
product 8 as a colourless oil (2.50 g, 37%); νmax (thin film) 2980 
(m), 1721 (s), 1403 (m); δH (400 MHz, CDCl3): 1.41 (3H, t, J 7.1, 
CH3), 1.50 [9H, s, (CH3)3], 4.38 (2H, q, J 7.1, CH2), 7.06 (1H, s, 
ArCH), 7.23 (1H, s, ArCH); δC (100 MHz, CDCl3): 14.2 (CH3), 30.1 
[(CH3)3], 58.7 [(CH3)3C], 61.6 (CH2), 122.2 (ArCH), 127.8 (ArCH), 
137.4 (ArC), 160.0 (CO); HRMS (ES+ TOF): found 197.1299 ([M + 
H]+); C10H17N2O2 requires 197.1290. 
1-Methyl-2-pyrrolecarboxylic acid 10 
Aqueous KOH (2.5 M, 20 mL, 50 mmol) was added to a 
solution of methyl 1-methylpyrrole-2-carboxylate 12 (2.1 g, 6.6 
mmol) dissolved in methanol (20 mL) at rt and the resulting 
reaction mixture was stirred overnight. Methanol was 
evaporated and the remaining solution was carefully acidified 
to pH 2 with hydrochloric acid (6 M). The white precipitate was 
collected by filtration and washed with water. The precipitate 
was dissolved in DCM (50 mL) and dried over MgSO4. The 
desiccant was filtered off and the filtrate was evaporated to 
give the product 10 as a white solid (1.1 g, 57%); m.p. 136–138 
°C (lit.28 135–136 °C); δH (400 MHz, CDCl3): 3.96 (3H, s, CH3), 
6.18 (1H, dd, J 4.0, 2.1, ArCH), 6.87 (1H, t, J 2.1, ArCH), 7.13 
(1H, dd, J 4.0, 2.1, ArCH), 12.20 (1H, br s, OH); δC (63 MHz, 
CDCl3): 37.0 (CH3), 108.4 (ArCH), 120.1 (ArCH), 121.8 (ArC), 
130.8 (ArCH), 166.6 (CO). NMR data was not previously 
reported in the literature. 
1-t-Butyl-1H-imidazole-2-carboxylic acid 11 
Aqueous KOH (2.5 M, 20 mL, 50 mmol) was added to a 
solution of ethyl 1-t-butyl-1H-imidazole-2-carboxylate 8 (1.29 
g, 6.6 mmol) in methanol (20 mL) at rt. The reaction mixture 
was stirred overnight, the methanol was evaporated and the 
mixture carefully acidified to pH 2 with concd. HCl. The 
resulting mixture was evaporated to give a white solid that 
was treated with methanol (30 mL) and filtered. The filtrate 
was evaporated to give the crude product 11 as a white solid 
(0.70 g) that was contaminated with a small amount of the t-
butyl imidazole compound formed by decarboxylation (~10%) 
but was used in the next step without further purification; δH 
(400 MHz, MeOD): 1.86 [9H, s, (CH3)3C], 7.71 (1H, d, J 1.8, 
ArCH), 8.02 (1H, d, J 1.8, ArCH); δC (100 MHz, MeOD): 28.3 
[(CH3)3], 63.9 [(CH3)3C], 119.1 (ArCH), 124.3 (ArCH), 134.8 
(ArC), 154.8 (CO); HRMS (ES+ TOF): found 169.0978 [M + H]+; 
C8H13N2O2 requires 169.0977;. Data for the N-t-butylimidazole 
contaminant; δH (400 MHz, MeOD): 1.72 [9H, s, (CH3)3], 7.63 
(1H, s, ArCH), 7.91 (1H, s, ArCH), 9.10 (1H, s, ArCH). 
(S)-[2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl](1-methyl-1H-
imidazol-4-yl)methanone 14 
Oxalyl chloride (0.18 mL, 2.1 mmol) was added to a mixture of 
1-methyl-1H-imidazole-4-carboxylic acid 9 (132 mg, 1.05 
mmol) in DCM (5 mL) at rt. One drop of DMF was added and 
the reaction mixture was stirred at room temperature for 2 h. 
Excess oxalyl chloride and DCM were removed by evaporation 
under reduced pressure. The residue was dissolved in DCM (5 
mL) and added to a solution of amino alcohol 13 (253 mg, 1.0 
mmol) and triethylamine (0.2 mL, 1.4 mmol) in DCM (5 mL). 
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The resulting mixture was stirred at rt for 2 h and then 
quenched with aqueous saturated NaHCO3 (15 mL). The 
aqueous phase was extracted with DCM (3 × 15 mL), and the 
combined organic extracts washed with brine (15 mL) and 
dried over MgSO4. The desiccant was filtered off and the 
filtrate was evaporated. The residue was purified by 
chromatography on silica gel (diethyl ether to flush off excess 
amino alcohol then 2% methanol in ethyl acetate) to yield the 
product 14 as a white solid (91 mg, 25%); m.p. 68–70 °C; []
 
-116.3 (c 0.94, CHCl3); νmax (thin film) 2924 (s), 2854 (m), 1587 
(m), 1556 (m), 1446 (m), 1434 (m); δH (500 MHz, 100 °C, 
DMSO-d6): 1.30–1.39 (1H, m, CHH), 1.51–1.60 (1H, m, CHH), 
1.88–1.94 (1H, m, CHH), 1.99–2.07 (1H, m, CHH), 3.28–3.34 
(1H, m, CHH), 3.63 (3H, s, CH3), 4.08–4.13 (1H, m, CHH), 5.67 
(1H, br s, CH), 6.63 (1H, s, ArCH), 7.15–7.20 (3H, m, ArCH), 
7.22–7.25 (1H, m, ArCH), 7.28–7.36 (5H, m, ArCH), 7.43–7.45 
(2H, m, ArCH), 7.50 (1H, s, ArCH); δC (126 MHz, 100 °C, DMSO-
d6): 22.4 (CH2), 27.6 (CH2), 32.4 (CH3), 48.3 (CH2), 64.3 (CH), 
80.8 (C), 125.1 (ArCH), 125.7 (ArCH), 126.0 (ArCH), 126.5 (2 × 
ArCH), 126.7 (2 × ArCH), 126.8 (2 × ArCH), 127.1 (2 × ArCH), 
136.4 (ArCH), 136.9 (ArC), 144.6 (ArC), 146.1 (ArC), 163.6 (CO); 
HRMS (ES+ TOF): found 362.1876 [M + H]+; C22H24N3O2 requires 
362.1869. 
(S)-[2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl](1-methyl-1H-
pyrrol-2-yl)methanone 15 
Oxalyl chloride (0.18 mL, 2.1 mmol) was added to a solution of 
1-methyl-2-pyrrolecarboxylic acid 10 (131 mg, 1.05 mmol) in 
DCM (5 mL) at room temperature. One drop of DMF was 
added and then the reaction mixture was stirred at rt for 2 h. 
Excess oxalyl chloride and DCM were removed by evaporation 
under reduced pressure. The residue was dissolved in DCM (5 
mL) and added to a solution of amino alcohol 13 (253 mg, 1 
mmol) and triethylamine (0.2 mL, 1.4 mmol) in DCM (5 mL). 
The resulting mixture was stirred at rt for 2 h and then 
quenched with aqueous saturated NaHCO3 (15 mL). The 
aqueous phase was extracted with DCM (3 × 15 mL), and the 
combined organic extracts washed with brine (15 mL) and 
dried over MgSO4. The desiccant was filtered off, the filtrate 
evaporated, and the residue purified by chromatography on 
silica gel [15% ethyl acetate in petroleum ether (40-60)] to 
yield the product 15 as a white solid (195 mg, 54%); m.p. 184–
186 °C; ; []
 -83.7 (c 0.86, CHCl3); (Found: C, 76.28; H, 6.64; 
N, 7.69. C23H24N2O2 requires C, 76.64; H, 6.71; N, 7.77%); νmax 
(thin film) 3246 (w), 2958 (w), 1588 (s), 1435 (s); δH (400 MHz, 
CDCl3): 1.42 (1H, pent d, J 7.5, 4.1, CHH), 1.61 (1H, d pent, J 
12.4, 8.8, CHH), 1.94–2.03 (1H, m, CHH), 2.18 (1H, dtd, J 12.4, 
8.8, 4.1, CHH), 2.92 (1H, td, J 10.0, 7.3, CHH), 3.76–3.79 (1H, m, 
CH), 3.81 (3H, s, CH3), 5.50 (1H, dd, J 8.4, 7.4, CH), 6.08 (1H, dd, 
J 3.9, 2.0, ArCH), 6.23 (1H, dd, J 3.9, 2.0, ArCH), 6.70 (1H, app t, 
J 2.0, ArCH), 6.75 (1H, br s, OH), 7.27–7.39 (6H, m, ArCH), 
7.48–7.50 (2H, m, ArCH), 7.55–7.58 (2H, m, ArCH); δC (100 
MHz, CDCl3): 24.5 (CH2), 29.3 (CH2), 36.3 (CH3), 51.6 (CH2), 66.8 
(CH), 82.7 (C), 107.1 (ArCH), 114.6 (ArCH), 125.5 (ArC), 127.1 
(ArCH), 127.2 (ArCH), 127.3 (ArCH), 127.4 (2 × ArCH), 127.9 (2 × 
ArCH), 128.0 (2 × ArCH), 128.2 (2 × ArCH), 143.1 (ArC), 145.7 
(ArC), 165.5 (CO); HRMS (ES+ TOF): found 361.1913 [M + H]+; 
C23H25N2O2 requires 361.1916.  
(S)-(1-t-Butyl-1H-imidazol-2-yl)[2-
(hydroxydiphenylmethyl)pyrrolidin-1-yl]methanone 16 
Oxalyl chloride (0.18 mL, 2.1 mmol) was added to the crude 
mixture of 1-t-butyl-1H-imidazole-2-carboxylic acid 11 (0.133 
mg, 1.05 mmol) in DCM (5 mL) at room temperature. One drop 
of DMF was added and then the reaction mixture was stirred 
at rt for 2 h. The excess oxalyl chloride and DCM were 
removed by evaporation under reduced pressure. The residue 
was dissolved in DCM (5 mL) and this added to a solution of 
amino alcohol 13 (253 mg, 1 mmol) and triethylamine (0.2 mL, 
1.4 mmol) in DCM (5 mL). The resulting mixture was stirred at 
rt for 2 h and then quenched with aqueous saturated NaHCO3 
(15 mL). The aqueous phase was extracted with DCM (3 × 15 
mL), and the combined organic extracts washed with brine (15 
mL) and dried over MgSO4. Filtration and evaporation was 
followed by purification by chromatography on silica gel 
[diethyl ether to flush off excess amino alcohol, then 50% ethyl 
acetate in petroleum ether (40–60)] yielding the product 16 as 
a white solid (110 mg, 26%); m.p. 157–159 °C; ; []
 -153.7 (c 
0.8, CHCl3); νmax (thin film) 2979 (w), 1618 (s), 1449 (s); δH (500 
MHz, 100 °C, DMSO-d6): 1.40 (1H, br s, CHH), 1.45 [9H, s, 
(CH3)3], 1.53–1.62 (1H, m, CHH), 1.93–1.99 (1H, m, CHH), 2.01–
2.08 (1H, m, CHH), 3.19–3.24 (1H, m, CHH), 3.46 (1H, br s, 
CHH), 5.41 (1H, dd, J 8.3, 3.3, CH), 6.22 (1H, br s, ArCH), 6.86 
(1H, s, ArCH), 7.13–7.16 (1H, m, ArCH), 7.20–7.25 (4H, m, 
ArCH), 7.29–7.32 (2H, m, ArCH), 7.42 (2H, d, J 7.5, ArCH), 7.48 
(2H, d, J 7.7, ArCH); δC (126 MHz, 100 °C, DMSO-d6): 22.2 (CH2), 
27.6 (CH2), 29.5 [(CH3)3C], 48.6 [(CH3)3C], 56.4 (CH2), 64.5 (CH), 
80.4 (C), 118.4 (ArCH), 125.4 (ArCH), 125.8 (ArCH), 126.1 
(ArCH), 126.6 (2 × ArCH), 126.7 (2 × ArCH), 126.9 (ArCH), 140.4 
(ArC), 144.9 (ArC), 145.8 (ArC), 163.7 (CO); HRMS (ES+ TOF): 
found 404.2348 [M + H]+; C25H30N3O2 requires 404.2338. 
General procedure A for the reduction of ketimines with catalysts 
Ketimine (1.0 mmol) and catalyst (mol% as specified) were 
dissolved in DCM (1 mL) at 0 oC. HSiCl3 (0.2 mL, 2.0 mmoL) was 
added and the reaction left to stir for the specified time. The 
reaction was quenched with aqueous HCl (1 M, 2 mL – care, 
gas evolution), followed by addition of DCM (20 mL) and 
aqueous NaOH (1 M, 20 mL), and stirred until the precipitate 
dissolved. The organic layer was separated and the aqueous 
layer was further extracted with DCM (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered and 
evaporated. Purification and analysis is detailed in individual 
amine products. 
Catalyst evaluation using (S)-N-(4-methoxyphenyl)-α-methyl-
benzenemethanamine 6 
Prepared by general procedure A, using 4-methoxy-N-(1-
phenylethylidene)-benzenamine 5 (225 mg, 1 mmol) and 
specified catalyst, gave the title compound 6. Conversion to 
product was determined by comparison of the integrals of 
signals in the 1H NMR spectrum, whilst the enantiomeric 
excess was determined by chiral phase HPLC analysis; δH (400 
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MHz, CDCl3): 1.52 (3H, d, J 7.1, CH3), 3.70 (3H, s, CH3), 4.43 (1H, 
q, J 7.1, CH), 6.49 [2H, (AX)2, ArCH], 6.72 [2H, (AX)2, ArCH], 
7.21–7.40 (5H, m, ArCH); Phenomenex Lux 3m cellulose-1, 
hexane/i-PrOH = 98/2, flow rate = 1.0 mL/min, 254 nm, (R) 
enantiomer tR = 16.5 min, (S) enantiomer tR = 19.3 min. 
(S)-α,α-Dimethyl-2-pyrrolinol 19
29
 
Mg (1.92 g, 80 mmol), iodine (one granule) and diethyl ether 
(20 mL) were added to a dry three-necked flask. A solution of 
MeI (4.98 g, 80 mmol) in THF (80 mL) was added dropwise 
(initiated by heat after about 5–10 mL addition). The mixture 
was stirred at rt for 2 h and then cooled to 0 °C. A solution of 
(S)-N-ethoxycarbonylproline methyl ester 18 (4.02 g, 20 mmol) 
in diethyl ether (20 mL) was added dropwise. The resulting 
mixture was stirred at rt overnight, cooled to 0 °C and 
quenched with saturated aqueous ammonium chloride (50 
mL). The organic layer was separated and the aqueous layer 
extracted with diethyl ether (2 × 50 mL). The combined organic 
extracts were evaporated to afford a yellow oil (3.36 g). This 
residue was treated with KOH (9.3 g, 0.166 mol), water (60 mL) 
and ethanol (40 mL), and heated at reflux overnight. The 
mixture was cooled to rt and the ethanol removed under 
reduced pressure. The resulting solution was extracted with 
DCM (2 × 50 mL), the combined extracts were washed with 
brine (30 mL) and dried over MgSO4. After filtration, the 
filtrate was evaporated under reduced pressure to afford the 
title compound 19 as a brown, low melting solid (1.87 g, 72%); 
[]
 -28.0 (c 2, MeOH, lit. -32.3,29 c 1.84, MeOH); δH (400 
MHz, CDCl3): 1.14 (3H, s, CH3), 1.18 (3H, s, CH3), 1.60–1.82 (4H, 
m, 2 × CH2), 2.84 (2H, br s, NH & OH), 2.90–3.05 (3H, m, CH2 & 
CH); δC (100 MHz, CDCl3): 25.2 (CH3), 26.1 (CH2), 26.3 (CH2), 
28.6 (CH3), 47.0 (CH2), 67.0 (CH), 70.3 (C); Data was in 
accordance with the literature.  
(S)-[2-(2-Hydroxypropan-2-yl)pyrrolidin-1-yl](1-methyl-1H-
imidazol-2-yl)methanone 21 
(S)-α,α-Dimethyl-2-pyrrolinol 19 (1.29 g, 10 mmol) was 
dissolved in toluene (10 mL) and NaH (60% dispersion in 
mineral oil, 600 mg, 15 mmol) was added at rt. After stirring 
for 30 min, ethyl 1-methylimidazole-2-carboxylate 20 (1.69 g, 
11 mmol) was added. The resulting reaction mixture was 
slowly warmed to 70 °C and stirred for 40 h. The reaction was 
cooled to rt, quenched by addition of water (20 mL) and 
extracted with ethyl acetate (3 × 30 mL). The combined 
organic phases were dried over MgSO4. After filtration, the 
filtrate was evaporated and purified by chromatography on 
silica gel [50% ~ 100% ethyl acetate in petroleum ether (40-
60)] to yield the product 21 (0.896 g, 39%) as a white solid; 
m.p. 84–86 °C; []
 -124 (c 1.1, CHCl3); (Found: C, 60.70; H, 
7.98; N, 17.70. C12H19N3O2 requires C, 60.74; H, 8.07, N, 
17.71%); νmax (thin film) 3353 (br m), 2974 (m), 1607 (s), 1455 
(s); δH (500 MHz, DMSO-d6, 100 
oC): 1.07 [6H, s, 2 x CH3], 1.65–
1.70 (1H, m, CHH), 1.89–1.95 (3H, m, CH2 & CHH), 3.49–3.54 
(1H, m, CHH), 3.79 (3H, s, CH3), 3.97–4.03 (1H, m, CHH), 4.42–
4.62 (1H, br m, OH), 4.71 (1H, br s, CH), 6.95 (1H, s, ArCH), 7.19 
(1H, s, ArCH); δC (126 MHz, DMSO-d6, 100 ºC): 23.4 (br, CH2), 
25.6 (CH2), 25.7 (CH3), 26.9 (CH3), 33.8 (CH3), 48.7 (br CH2), 
65.2 (CH), 72.4 (C), 123.5 (ArCH), 126.1 (ArCH), 140.4 (ArC), 
160.4 (CO); HRMS (ES+ TOF): found 238.1556 [M + H]+; 
C12H20N3O2 requires 238.1550. 
(S)-[2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl](pyridin-2-
yl)methanone 23 
Oxalyl chloride (1.32 mL, 15 mmol) was added dropwise to a 
solution of picolinic acid (615 mg, 5 mmol) in DCM (15 mL). 
The resulting mixture was stirred at rt for 4 h, followed by 
evaporation to give a black solid. DCM (20 mL) was added and 
the suspension transferred into a solution of (S)-α,α-
diphenylprolinol 13 (1.02 g, 4 mmol) in toluene (20 mL) and 
the resulting mixture stirred at rt overnight. The reaction was 
quenched by aqueous ammonium chloride (20 mL) and 
extracted with ethyl acetate (3 × 20 mL). The combined 
organic extracts were dried over Na2SO4, filtered, evaporated 
under reduced pressure, and the residue purified by 
chromatography on silica gel [20% ~ 100% ethyl acetate in 
petroleum ether (40-60)] to yield the product 23 as white solid 
(950 mg, 66%); m.p. 129–131 °C (not reported in literature); 
[]
 -118.7 (c 0.8, CHCl3, not reported in literature); νmax (thin 
film) 3058 (w), 2989 (w), 1608 (s), 1565 (s); δH (500 MHz, 
DMSO-d6, 100 
oC): 1.63–1.80 (2H, m, CH2), 1.92–1.98 (1H, m, 
CHH), 2.05–2.12 (1H, m, CHH), 3.47–3.52 (1H, m, CHH), 3.65 
(1H, br s, CHH), 5.72 (1H, br s, OH), 5.85 (1H, br s, CH), 7.06–
7.26 (7H, m, ArCH), 7.32–7.35 (3H, m, ArCH), 7.48 (2H, d, J 7.6, 
ArCH), 7.69 (1H, br s, ArCH), 8.48 (1H, d, J 3.9, ArCH); δC (126 
MHz, d6-DMSO, 100 
oC): 22.7 (br, CH2), 27.4 (CH2), 48.6 (br, 
CH2), 63.9 (CH), 81.0 (C), 122.8 (ArCH), 123.7 (ArCH), 125.8 (2 × 
ArCH), 126.1 (2 × ArCH), 126.5 (2 × ArCH), 126.7 (2 × ArCH), 
127.0 (2 × ArCH), 136.1 (ArCH), 145.0 (ArC), 145.4 (ArC), 146.9 
(br, ArC), 154.0 (ArCH), 166.9 (br, CO); HRMS (ES+ TOF): found 
359.1769 [M + H]+; C23H23N2O2 requires 359.1760. 
(S)-[2-(Methoxydiphenylmethyl)pyrrolidin-1-yl](1-methyl-1H-
imidazol-2-yl)methanone 26 
NaH (60% dispersion in mineral oil, 44 mg, 1.1 mmol) was 
added to a solution of hydroxy catalyst 17 (361 mg, 1 mmol) in 
THF (10 mL). After stirring for 20 min at rt, MeI (156 mg, 1.1 
mmol) was added dropwise at the same temperature and then 
stirred overnight. The resulting mixture was quenched with 
saturated aqueous ammonium chloride (10 mL). The organic 
phase was separated and the aqueous phase was extracted 
with DCM (3 × 10 mL). The combined organic extracts were 
dried over MgSO4. After filtration and evaporation, the residue 
was purified by chromatography on silica gel [20% ∼ 50% ethyl 
acetate in petroleum ether (40-60)] to yield the product 26 as 
a white foam as a 4.6:1 mixture of two rotamers A and B (0.21 
g, 56%); m.p. 93–95 °C; []
 -68 (c 0.5, CHCl3); νmax (thin film) 
2927 (w), 1624 (s), 1524 (m), 1463 (s); δH (400 MHz, CDCl3, 
rotamer A): 1.03–1.16 (1H, m, CHH), 1.57–1.68 (1H, m, CHH), 
1.98–2.05 (1H, m, CHH), 2.25–2.48 (2H, m, CH2), 2.38 (3H, s, 
CH3), 3.54–3.61 (1H, m, CH), 3.79 (3H, s, CH3), 6.31 (1H, d, J 
8.9, CH), 6.79 (1H, d, J 0.9, ArCH), 6.95 (1H, d, J 0.9, ArCH), 
7.26–7.36 (7H, m, ArCH), 7.46–7.52 (1H, m, ArCH); δH (400 
MHz, CDCl3, rotamer B): 1.03–1.16 (1H, m, CHH), 1.45–1.53 
(1H, m, CHH), 1.98–2.05 (1H, m, CHH), 2.95–3.02 (1H, m, CHH), 
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3.00 (3H, s, CH3), 3.70–3.76 (1H, m, CHH), 3.86 (3H, s, CH3), 
5.72 (1H, dd, J 8.7, 3.1, CH), 6.89 (1H, s, ArCH), 7.07 (1H, s, 
ArCH), 7.26–7.36 (8H, m, ArCH); δC (100 MHz, CDCl3, rotamer 
A): 21.8 (CH2), 27.6 (CH2), 34.2 (CH3), 47.4 (CH2), 51.8 (CH3), 
63.5 (CH), 86.8 (C), 122.4 (ArCH), 126.6 (ArCH), 127.6 (3 × 
ArCH), 127.7 (3 × ArCH), 129.4 (2 × ArCH), 130.0 (2 × ArCH), 
138.8 (ArC), 139.7 (ArC), 142.6 (ArC), 161.2 (CO); δC (100 MHz, 
CDCl3, rotamer B): 23.9 (CH2), 26.6 (CH2), 29.7 (CH2), 35.4 (CH3), 
50.7 (CH2), 52.5 (CH3), 60.4 (CH), 86.7 (C), 123.9 (ArCH), 127.4 
(2 × ArCH), 127.5 (2 × ArCH), 127.8 (3 × ArCH), 129.6 (3 × 
ArCH), 129.9 (ArCH), 140.1 (ArC), 140.9 (ArC), 141.2 (ArC), 
161.2 (CO); HRMS (ES+ TOF): found 376.2023 [M + H]+; 
C23H26N3O2 requires 376.2025. 
(S)-[2-(Methoxydiphenylmethyl)pyrrolidin-1-yl](pyridin-2-
yl)methanone 27 
NaH (60% dispersion in mineral oil, 80 mg, 2 mmol) was added 
to a solution of alcohol 23 (358 mg, 1 mmol) in THF (8 mL). 
After stirring for 15 min at rt, MeI (284 mg, 2 mmol) was added 
dropwise at rt and left to stir overnight. The resulting mixture 
was quenched with saturated aqueous ammonium chloride 
(20 mL). The organic phase was separated and the aqueous 
phase was extracted with ethyl acetate (3 × 15 mL). The 
combined organic extracts were dried over Na2SO4, filtered, 
evaporated, and the resulting residue purified by 
chromatography on silica gel [10% ~100% ethyl acetate in 
petroleum ether (40-60)] to yield the product 27 as a yellow 
solid as a 2 : 1 mixture of rotamers A and B (308 mg, 83%); 
m.p. 104–106 °C; []
 -154 (c 1.0, CHCl3); νmax (thin film) 3056 
(m), 2961 (m), 1626 (s), 1587 (s), 1556 (s); δH (400 MHz, CDCl3, 
rotamer A): 1.04–1.16 (1H, m, CHH), 1.59–1.70 (1H, m, CHH), 
1.94–2.01 (1H, m, CHH), 2.31 (3H, s, CH3), 2.37–2.45 (2H, m, 
CH2), 3.65–3.72 (1H, m, CH), 6.20 (1H, dd, J 9.2, 1.6, CH), 7.25–
7.39 (9H, m, ArCH), 7.52 (1H, d, J 9.1, ArCH), 7.60 (1H, d, J 6.7, 
ArCH), 7.59–7.78 (2H, m, ArCH), 8.54 (1H, d, J 4.8, ArCH); δH 
(400 MHz, CDCl3, rotamer B): 1.04–1.16 (1H, m, CH), 1.44–1.55 
(1H, m, CH), 2.02–2.11 (1H, m, CH), 2.13–2.23 (1H, m, CH), 
2.71–2.78 (1H, m, CH), 3.07 (3H, s, CH3), 3.15–3.21 (1H, m, CH), 
5.80 (1H, dd, J 9.1, 3.2, CH), 7.25–7.39 (11H, m, ArCH), 7.59–
7.78 (2H, m, ArCH), 8.65 (1H, d, J 4.6, ArCH); δC (100 MHz, 
CDCl3, rotamer A): 21.6 (CH2), 27.8 (CH2), 47.7 (CH2), 50.7 (CH), 
64.0 (CH3), 87.0 (C), 123.7 (ArCH), 124.3 (ArCH), 127.3 (2 × 
ArCH), 127.6 (ArCH), 127.7 (2 × ArCH), 127.8 (ArCH), 127.9 
(ArCH), 129.6 (ArCH), 129.8 (ArCH), 129.9 (ArCH), 130.0 (ArCH), 
138.4 (ArC), 138.6 (ArC), 146.9 (ArCH), 156.6 (ArC), 168.5 (CO); 
δC (100 MHz, CDCl3, rotamer B): 24.0 (CH2), 26.9 (CH2), 50.6 
(CH2), 52.3 (CH), 59.8 (CH3), 86.6 (C), 124.5 (ArCH), 127.3 
(ArCH), 127.6 (ArCH), 127.7 (2 × ArCH), 127.8 (ArCH), 127.9 
(ArCH), 129.6 (ArCH), 129.8 (ArCH), 129.9 (ArCH), 130.0 (ArCH), 
136.4 (2 × ArCH), 140.5 (ArC), 141.9 (ArC), 148.7 (ArCH), 155.0 
(ArC), 169.1 (CO); HRMS (ES+ TOF): found 373.1917 [M + H]+; 
C24H25N2O2 requires 373.1916. 
(S)-N-[1-Phenylethyl]-4-fluoroaniline 34
26 
Obtained using general procedure A with ketimine 29, 
employing catalyst 17 (1 mol%, 96% conversion, 87% ee) or 
catalyst 26 (0.1 mol%, 95% conversion, 86% ee) as a light 
yellow oil; ; []
 +23.8 (c 1.05, CHCl3, 87% ee, lit.
26 -16.8, c 
1.0, CHCl3, 84% ee for R-enantiomer); δH (400 MHz, CDCl3): 
1.52 (3H, d, J 6.6, CH3), 4.03 (1H, br s, NH), 4.45 (1H, q, J 6.6, 
CH), 6.43–6.47 (2H, m, ArCH), 6.79–6.84 (2H, m, ArCH), 7.23–
7.28 (1H, m, ArCH), 7.32–7.38 (4H, m, ArCH); δC (101 MHz, 
CDCl3): 25.1 (CH3), 54.1 (CH), 114.1 (d, JC-F 6.9, ArCH), 115.5 (d, 
JC-F 22.2, ArCH), 125.9 (ArCH), 127.0 (ArCH), 128.8 (ArCH), 
143.7 (ArC), 145.1 (ArC), 155.5 (d, JC-F 234.6, ArC); HPLC 
(Kromasil 3-Cellucoat OD, hexane/i-PrOH = 99/1, flow rate = 
1.0 mL/min, 254 nm): (R) enantiomer tR = 6.9 min, (S) 
enantiomer tR = 7.8 min. 
(S)-N-[1-(4’-Methoxyphenyl)ethyl]-4-methoxyaniline 35
16 
Obtained using general procedure A with ketimine 30, 
employing catalyst 26 (0.1 mol%, 97% conversion, 84% ee) as a 
white solid; m.p. 93–95 ºC (not reported in literature); []
 -
14.5 (c 0.96, CHCl3, 81% ee, lit. -15.5,
16 c 1.1, CHCl3, 85% ee); δH 
(250 MHz, CDCl3): 1.49 (3H, d, J 6.6, CH3), 3.72 (3H, s, CH3), 
3.76 (1H, br s, NH), 3.80 (3H, s, CH3), 4.39 (1H, q, J 6.6, CH), 
6.49 [2H, (AX)2, ArCH], 6.71 [2H, (AX)2, ArCH], 6.87 [2H, (AX)2, 
ArCH], 7.29 [2H, (AX)2, ArCH]; δC (63 MHz, CDCl3): 25.1 (CH3), 
53.7 (CH3), 55.3, (CH3), 55.8 (CH3), 114.0 (2 × ArCH), 114.6 (2 × 
ArCH), 114.8 (2 × ArCH), 127.0 (2 × ArCH), 137.6 (ArC), 141.7 
(ArC), 151.9 (ArC), 158.5 (ArC); HPLC (Phenomenex Lux 3m 
Cellulose-1, hexane/i-PrOH = 90/10, flow rate = 1.0 mL/min, 
254 nm): (R) enantiomer tR = 9.1 min, (S) enantiomer tR = 10.0 
min. 
(S)-N-[1-(4’-Nitrophenyl)ethyl]-4-methoxyaniline 36
16
 
Obtained using general procedure A with ketimine 31, 
employing catalyst 26 (0.1 mol%, 98% conversion, 84% ee) as a 
brown oil; []
 -30.8 (c 1.0, CHCl3, 84% ee, lit. -25.9,
16 c 0.54, 
CHCl3, 86% ee); δH (400 MHz, CDCl3): 1.55 (3H, d, J 6.8, CH3), 
3.72 (3H, s, CH3), 3.93 (1H, br s, NH), 4.53 (1H, q, J 6.8, CH), 
6.43 (2H, d, J 8.2, ArCH), 6.72 (2H, d, J 8.2, ArCH), 7.57 (2H, d, J 
8.8, ArCH), 8.20 (2H, d, J 8.8, ArCH); δC (101 MHz, CDCl3): 25.0 
(CH3), 54.0 (CH3), 55.7 (CH), 114.5 (2 × ArCH), 114.8 (2 × ArCH), 
124.1 (2 × ArCH), 126.8 (2 × ArCH), 140.8 (ArC), 147.0 (ArC), 
152.3 (ArC), 153.6 (ArC); HPLC (Phenomenex Lux 3m 
Cellulose-1, hexane/i-PrOH = 90/10, flow rate = 1.0 mL/min, 
254 nm): (R) enantiomer tR = 28.3 min, (S) enantiomer tR = 31.8 
min. 
(S)-N-[1-(Thiophen-2-yl)ethyl]-4-methoxyaniline 37
17
 
Obtained using general procedure A with ketimine 32, 
employing catalyst 26 (0.1 mol%, 77% conversion, 80% ee) as a 
yellow oil; []
 -8.0 (c 1.0, CHCl3, 79% ee, lit.
17 -8.0, c 1.0, 
CHCl3, 79% ee); δH (250 MHz, CDCl3): 1.63 (3H, d, J 6.6, CH3), 
3.75 (3H, s, CH3), 4.76 (1H, q, J 6.6, CH), 6.62 [2H, (AX)2, ArCH], 
6.75 [2H, (AX)2, ArCH], 6.94–6.98 (2H, m, ArCH), 7.18 (1H, dd, J 
4.7, 1.6, ArCH); δC (63 MHz, CDCl3): 24.8 (CH3), 50.6 (CH3), 55.8 
(CH), 114.9 (2 × ArCH), 115.2 (2 × ArCH), 123.0 (ArCH), 123.6 
(ArCH), 126.7 (ArCH), 141.2 (ArC), 150.6 (ArC), 152.5 (ArC); 
HPLC (Phenomenex Lux 3m Cellulose-1, hexane/i-PrOH = 
98/2, flow rate = 1.0 mL/min, 254 nm): (R) enantiomer tR = 
15.1 min, (S) enantiomer tR = 17.3 min. 
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(S)-N-[1-(Naphthalen-2-yl)ethyl]-4-methoxyaniline 38
16 
Obtained using general procedure A with ketimine 33, 
employing catalyst 26 (0.1 mol%, 99% conversion, 92% ee) as a 
light yellow solid; m.p. 96–98 °C (lit.16 95–96 oC); []
 -24.0 (c 
1.0, CHCl3, 85% ee, lit.
16 -26.0, c 1.0, CHCl3, 86% ee); δH (250 
MHz, CDCl3): 1.59 (3H, d, J 6.9, CH3), 3.70 (3H, s, CH3), 3.90 (1H, 
br s, NH), 4.59 (1H, q, J 6.9, CH), 6.53 [2H, (AX)2, ArCH], 6.71 
[2H, (AX)2, ArCH], 7.42–7.55 (3H, m, ArCH), 7.80–7.86 (4H, m, 
ArCH); δC (63 MHz, CDCl3): 25.2 (CH3), 54.6 (CH3), 55.8 (CH), 
114.7 (ArCH), 114.8 (ArCH), 124.4 (ArCH), 124.5 (ArCH), 125.5 
(ArCH), 126.0 (ArCH), 127.7 (ArCH), 127.9 (ArCH), 128.5 (ArCH), 
132.8 (ArC), 133.7 (ArC), 141.7 (ArC), 143.1 (ArC), 152.0 (ArC); 
HPLC (Phenomenex Lux 3m Cellulose-1, hexane/i-PrOH = 
90/10, flow rate = 1.0 mL/min, 254 nm): (R) enantiomer tR = 
10.1 min, (S) enantiomer tR = 12.0 min. 
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